ArticlePharmacoepidemiology2022

Evaluation of the Effectiveness of Buprenorphine-Naloxone on Opioid Overdose and Death among Insured Patients with Opioid Use Disorder in the United States.

Tianyu Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.